Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LIN | BE |
|---|---|---|
| Price | $470.08 | $264.73 |
| Change today | ▲ 0.08% | ▼ 3.80% |
| Market cap | $216.70B | $77.97B |
| Return, 3 months | -8.6% | -18.8% |
| Return, year to date | +11.3% | +204.7% |
| Return, 1 year | +0.5% | +282.7% |
| P/E (TTM) | 30.3 | 343.8 |
| P/B | 5.5 | 48.4 |
| P/E percentile vs own 5y | 5th | 85th |
| Dividend yield | 1.32% | – |
| Revenue growth (YoY, latest qtr) | +9.3% | +165.5% |
| Net profit growth (YoY) | +9.2% | +571.3% |
| Gross margin | 48.3% | 31.2% |
| Operating margin | 27.1% | 11.2% |
| Net margin | 20.4% | 7.9% |
| Return on equity | 18.7% | 22.2% |
| Analyst target vs. price | +19.2% | +5.2% |
| Analyst buy share | 85% | 53% |
| RSI (14) | 48 | 61 |
| 30-day volatility | 15.7% | 77.7% |
| Max drawdown, 1 year | -19.2% | -52.7% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.